| Literature DB >> 29334948 |
Mebrahtu Tedla1, Nega Berhan2, Wassie Molla3, Wudu Temesgen4, Sefinew Alemu3.
Abstract
BACKGROUND: Orf virus, the prototype of parapoxvirus, is the main causative agent of contagious ecthyma. Little is known about the status of the disease in Ethiopia and this study was aimed at determining its status using PCR as a confirmatory tool.Entities:
Keywords: Cytopathic effect; Incidence; Orf virus; PCR; Risk factors; Sheep and goat
Mesh:
Substances:
Year: 2018 PMID: 29334948 PMCID: PMC5769459 DOI: 10.1186/s12917-018-1339-x
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Fig. 1Geographic location of the study areas
Fig. 2Typical clinical lesions of contagious ecthyma in different body parts. a) nostrils and mouth region, b) ear, c) teat and udder
Fig. 3a) Normal cells before viral transfection; b) Cells are trypsinized and appeared as a single cell; c & d) showing the peculiar feature of the cytopathic effects after 2 days of incubation
Fig. 4The band size of 140 bp is the amplified product of B2L gene which is a confirmatory for the presence of the Orf virus on the clinical samples. M represents a 10,000 bp molecular weight marker and S1-S10 represents the unknown samples tested and NS is the negative sample. Whereas, NC is the negative control
Univariate logistic regression analysis of the prevalence of Orf Virus infection with different putative risk factors
| Body part lesion | N | No. Positive | Prevalence, % (95% CI) | |
|---|---|---|---|---|
| Mouth | 121 | 24 | 19.80 (14.71–23.22) | |
| Nostrils | 153 | 16 | 10.50 (8.03–12.45) | 0.041 |
| Teat and udder | 78 | 7 | 8.97 (5.98–11.32) | |
| Lower leg | 50 | 1 | 2.00 (0.98–3.45) | |
| Total | 400 | 48 | 12.00 (11.21–14.87) | |
| Species | ||||
| Goat | 200 | 17 | 8.5 (7.23–10.11) | 0.054 |
| Sheep | 200 | 31 | 15.5 (13.43–17.26) | |
| Total | 400 | 48 | 12.00 (11.21–14.87) | |
| Sex | ||||
| Male | 190 | 21 | 11.05 (9.86–14.36) | 0.32 |
| Female | 210 | 27 | 12.85 (10.03–15.88) | |
| Total | 400 | 48 | 12.00 (11.21–14.87) | |
| Body condition | ||||
| Poor | 155 | 27 | 17.4 (14.01–19.23) | 0.043 |
| Medium | 130 | 12 | 9.20 (7.01–12.87) | |
| Good | 115 | 9 | 7.80 (5.44–9.06) | |
| Total | 400 | 48 | 12.00 (11.21–14.87) | |
| Age | ||||
| < 1 year | 47 | 3 | 6.4 (4.49–9.67) | |
| 1–2 year | 133 | 22 | 16.5 (12.54–19.98) | 0.65 |
| 2–3 year | 152 | 14 | 9.2 (6.31–12.03) | |
| > 4 years | 68 | 9 | 13.2 (12.79–15.02) | |
| Total | 400 | 48 | 12.00 (11.21–14.87) | |
| Nursing | ||||
| Yes | 88 | 15 | 17.04 (14.01–21.39) | 0.047 |
| No | 312 | 33 | 10.57 (7.75–11.64) | |
| Total | 400 | 48 | 12.00 (11.21–14.87) | |
| Treatment and Vaccination | ||||
| Treated with anthelmentics | 121 | 11 | 9.1 (7.01–12.20) | 0.021 |
| Not treated with anthelmentics | 49 | 7 | 14.3 (11.10–17.09) | |
| Treated with antibiotics | 112 | 9 | 8.0 (6.93–10.05) | |
| Not treated with antibiotics | 35 | 6 | 17.14 (13.67–21.39) | |
| Any vaccination history | 46 | 7 | 15.21 (12.32–17.66) | |
| No any vaccination history | 37 | 8 | 21.62 (17.31–24.89) | |
| Total | 400 | 48 | 12.00 (11.21–14.87) | |
| Management System | ||||
| Extensive | 106 | 15 | 14.15 (11.05–17.08) | 0.042 |
| Semi extensive | 94 | 11 | 11.70 (7.88–13.09) | |
| Mixed | 81 | 9 | 11.11 (7.64–13.04) | |
| Free housing | 56 | 10 | 18.18 (15.03–21.80) | |
| Protected housing | 63 | 3 | 4.76 (2.44–7.42) | |
| Total | 400 | 48 | 12.00 (11.21–14.87) | |
| Study Area | ||||
| Gondar Zuria | 160 | 21 | 13.12 (10.19–15.32) | 0.65 |
| Ambagiorgis | 135 | 14 | 10.37 (7.83–13.09) | |
| Addis Zemen | 105 | 13 | 12.38 (8.21–14.39) | |
| Total | 400 | 48 | 12.00 (11.21–14.87) | |
| Type of Treatment | No. Responding | |||
| Moist dressing | 32 | 15.2 (12.1–19.64) | 0.032 | |
| Surgical removal | 57 | 27.1 (21.3–31.24) | ||
| Culling | 26 | 12.4 (9.02–15.62) | ||
| Antibiotics | 95 | 45.2 (39.56–45.42) | ||
| Total | 210 | |||
| Outbreak history | ||||
| Yes | 280 | 70 (64.10–74.50) | 0.012 | |
| No | 120 | 30 (27.21–34.52) | ||
| Total | 400 | |||